Liver transplant is the goal treatment for every patient with end-stage chronic liver disease.

Quality of life improves after transplant because the main complications of end-stage liver disease disappear, but due to immunosuppression other alterations appear such as metabolic alterations, weight gain, among others.

Body composition and nutritional status can be affected do to post-transplant pharmacologic therapy.

Body composition and nutritional status can be affected due to post-transplant pharmacologic therapy.

This is a prospective cohort study, patients from liver transplant waiting list will be assessed, pre and post-transplant measures of body composition and nutritional status will be obtained.

Inclusion Criteria:

• Liver cirrhosis (any etiology)
• Enrolled in waiting list for tliver transplant

Exclusion Criteria:

• Hepatocellular carcinoma
• Chronic renal failure
• Congestive cardiac failure
• Extremity amputation
• Pregnancy

Patients will be selected from the transplant enrollment list at the Department of Gastroenterology in a tertiary care center in Mexico